Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Mar 4:5:31.
doi: 10.4103/2152-7806.128182. eCollection 2014.

Synchronous multicentric glioblastoma with PNET and O subtypes: Possible pathogenesis

Affiliations
Case Reports

Synchronous multicentric glioblastoma with PNET and O subtypes: Possible pathogenesis

Kai Rui Wan et al. Surg Neurol Int. .

Abstract

Background: Glioblastomas (GBM) are highly infiltrative, cellular and mitotically active tumors with large histologic variations within and between tumours. Several subtypes have been described including the GBM with oligodendroglial differentiation (GBM-O) and primitive neuroectodermal tumour components (GBM-PNET). We report the first described case of a patient with synchronous multi-centric GBM-O and GBM-PNET components.

Case description: A patient, who presented with a short history of progressive headache and difficulty with memory recall, was found on MRI imaging to have two intracranial lesions. These showed heterogeneous enhancement and were found in the left frontal and left temporal regions. The patient underwent gross total resection of these two lesions which were found to show GBM-O and GBM-PNET differentiations.

Conclusion: Although tumour cell migration in the context of GBM is a well-recognized phenomenon, the traditional hypothesis is not able to satisfactorily explain this case of multicentric GBM whereby the two lesions demonstrate different cell origins. More current understanding of the migratory pathways from the subventricular zone provide an alternate and plausible pathway that fits our patient's unusual diagnosis.

Keywords: Glioblastoma; migration; oligodendroglial differentiation; pathogenesis; primitive neuroectodermal tumour; subventricular zone.

PubMed Disclaimer

Figures

Figure 1
Figure 1
T2-weighted (a) and T1-weighted (b) MRI showing synchronous tumour in the left frontal and temporal regions with solid and necrotic-cystic areas with significant perilesionaledema. (c) T1-weighted image post-gadolinium contrast showed heterogenous enhancement
Figure 2
Figure 2
(a) The glioblastoma component of the left temporal lobe tumour showing neoplastic astrocytes with pleomorphic nuclei and fibrillary cytoplasm. There was frequent mitotic activity and microvascular proliferation (right of field) (H and E, ×200). (b) The CNS PNET component of the left temporal lobe tumour showing densely packed cells with hyperchromatic oval to elongated nuclei, high nuclear cytoplasmic ratios and brisk mitotic activity (H and E, ×400). (c) GFAP staining in the glioblastoma cells (GFAP, ×200). (d) Synaptophysin was positive in the PNET-like component (Synaptophysin ×400)
Figure 3
Figure 3
(a) The glioblastoma component of the left frontal lobe tumour showing neoplastic astrocytes with pleomorphic nuclei and fibrillary cytoplasm. There was frequent mitotic activity, microvascular proliferation (right of field) and pseudopalisading necrosis (left of field) (H and E, ×200). (b) The oligodendroglial component of the left frontal lobe tumour (H and E, ×400)
Figure 4
Figure 4
The likely migratory pathway of transformed GSCs and, or their progenitors from the stem-cell enriched subventricular zone (SVZ) to the subcortical region

Similar articles

Cited by

References

    1. Arcos A, Romero L, Serramito R, Santin JM, Prieto A, Gelabert M, et al. Multicentric glioblastoma multiforme. Report of 3 cases, clinical and pathological study and literature review. Neurocirugia. 2012;23:211–5. - PubMed
    1. Achanta P, Sedora Roman NI, Quinones-Hinojosa A. Gliomagenesis and the use of neural stem cells in brain tumor treatment. Anticancer Agents Med Chem. 2010;10:121–30. - PMC - PubMed
    1. Appin CL, Gao J, Chisolm C, Torian M, Alexis D, Vincentelli C, et al. Glioblastoma with oligodendroglioma component (GBM-O): Molecular genetic and clinical characteristics. Brain Pathol. 2013;23:454–61. - PMC - PubMed
    1. Barnard RO, Geddes JF. The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections. Cancer. 1987;60:1519–31. - PubMed
    1. Bergstrom T, Forsberg-Nilsson K. Neural stem cells: Brain building blocks and beyond. Upsala J Med Sci. 2012;117:132–42. - PMC - PubMed

Publication types